Article
Programmable DNA Nanocages Enhance Levodopa Delivery for Neuroprotection in a Zebrafish Model of Parkinson’s Disease
2026-08-04
Abstract excerpt
Parkinson’s Disease (PD) is the second-most prevalent neurodegenerative disease, often characterized by neural motor dysfunction, oxidative stress, and dopamine receptor malfunction leading to improper dopamine levels in the system. DNA tetrahedron nanostructures are a promising drug delivery agent due to their biocompatibility and properties of controlled and sustained release. In this study we evaluated the pote...
Topics
Open a Topic to create a Post that cites this publication.
- Alzheimer's disease research and treatments
- Nanoparticles: synthesis and applications
- Nerve injury and regeneration
- Neuroinflammation and Neurodegeneration Mechanisms
- Neurological disorders and treatments
- Parkinson's Disease Mechanisms and Treatments
- RNA Interference and Gene Delivery
- Zebrafish Biomedical Research Applications
Identifiers and source
- Literature Corpus work
- c1582de1-63a4-5568-a46e-ea28c35d08ba
- DOI
- 10.64898/2026.08.04.742731
